Over 1 million screens
75,000+ genetic counseling
250+ million lives
We provide women and their families with actionable information to guide critical and timely health decisions. We seek to transform the execution and delivery of complex genetic testing through our three high-value screens and comprehensive suite of end-to-end workflow solutions for healthcare providers.
Counsyl operates a high-complexity clinical laboratory that offers the Foresight™ Carrier Screen, Prelude™ Prenatal Screen and Reliant™ Cancer Screen, and we offer supporting services through Counsyl Complete™, a proprietary suite of solutions, each designed to seamlessly integrate into clinic workflows and patients’ lives. Our genetic screens provide actionable information to patients and their healthcare providers through an easy-to-use and transparent process that facilitates clinical decision-making. Our custom-designed clinical laboratory provides highly reliable results, fast test processing speeds and rapid scalability, all at low capital and operating costs.
Counsyl launched our first commercial screen in 2009, and in January 2018 we reached a milestone of having delivered one million patient results.
Counsyl Prelude Prenatal Screen patient
Pictured with her fiancé, Sejin
Build with a beginner’s mind
Counsylors see many possibilities and approach situations with an open mind.
Counsylors check egos at the door and strive to do excellent work together.
Own it and make it happen
Counsylors take initiative and hold ourselves and each other accountable.
Produce more than you consume
Counsylors are in it for the long-haul, creating value for everyone through high performance and efficient use of resources.
Counsylors are a committed team, passionate about improving lives.
Eric A. Evans, PhD, Chief Science Officer, Myriad Women's Health
Dr. Eric Evans is currently chief science officer at Myriad Women’s Health where he oversees research and development. Prior to this role, Eric was co-founder and chief science officer of Counsyl. He joined the founding team to blend his scientific research and knowledge with real-world patient and doctor experiences. Eric is an expert in next-generation sequencing, molecular diagnostics, and molecular genetics. His research has been published in scientific journals including Aging Cell, Reproductive Biology & Endocrinology, PLoS Pathogens, and Genetics in Medicine. Eric is a certified High-Complexity Laboratory Director and Clinical Genetic Molecular Biologist Scientist. Eric holds a Ph.D. in genetics from Stanford University. He was the recipient of a National Science Foundation Research Fellowship as well as a Stanford Graduate Fellowship.
Rishi Kacker, Chief Technology Officer, Myriad Genetics, Inc.
Rishi is chief technology officer at Myriad Genetics, Inc. Prior to joining Myriad Genetics, Inc., Rishi co-founded Counsyl and served as the head of Counsyl’s engineering and product development teams, building a platform for modern diagnostic lab services including on-demand genetic counseling, automated results delivery, clinical interpretation, medical billing and lab information management. Rishi’s focus is bringing together software with the human touch to make genetic screening a routine part of clinical care. His expertise is taking traditionally complex systems and making them simple, scalable and accessible. Prior to Counsyl, he co-founded Voltage Security, a cryptography and data security startup which was acquired by HP Enterprise (NYSE: HPE). Rishi holds a B.S. in computer science from Stanford University.
MD, FACOG, FACMG,
Dr. James D. Goldberg,
MD, FACOG, FACMG, Chief Medical Officer, Myriad Women's Health
Dr. Goldberg is the chief medical officer of Myriad Women’s Health. Previously, Dr. Goldberg was chief medical officer at Counsyl where he led Counsyl’s collaboration with the medical community, executing high-impact clinical studies, and helping educate patients and physicians on screening benefits. He is board-certified in obstetrics and gynecology, maternal-fetal medicine, and medical genetics, and is a founding fellow of the American College of Medical Genetics. He was previously the director of the Reproductive Genetics Unit at the University of California, San Francisco and subsequently co-director of the Prenatal Diagnosis Center at California Pacific Medical Center and partner at San Francisco Perinatal Associates. Dr. Goldberg has also served as president of the Perinatal Quality Foundation and on the board of the Society for Maternal Fetal Medicine. He has published extensively in the area of prenatal diagnosis and has served on committees that establish national policy in obstetrical care.
Joel Jung, Chief Financial Officer, Counsyl
Joel Jung joined Counsyl with nearly 20 years of experience as an executive in the life sciences industry. Most recently, Joel was the chief financial officer of BioNano Genomics, a privately held company that is developing a new genomic mapping platform. Prior to BioNano, Joel was the chief financial officer and treasurer of AgraQuest, a privately held biotechnology company, where he played an integral role in the company’s acquisition by Bayer in 2012. Before AgraQuest, Joel was the chief financial officer and treasurer for the Celera Corporation where he led the financial team in the spinout from the Applera Corporation, listing the company as an independent, publicly traded company. Joel’s experience also includes working at Chiron Corporation for 11 years in several executive financial positions. He began his finance career at Bank of America. Joel earned an MBA from the University of California, Berkeley, Haas School of Business and a B.S. from Purdue University.
Noah Nasser, Chief Commercial Officer, Myriad Women's Health
Noah Nasser is the chief commercial officer of Myriad Women’s Health., Previously, Noah served as Counsyl’s chief commercial officer, responsible for commercial strategy and operations, sales, marketing, market intelligence, and customer service. With more than 25 years of experience in life sciences and diagnostics, Noah fosters a deep understanding of clinician’s needs and how to connect them with the right products. Prior to joining Counsyl, Noah served as senior vice president of sales at San Diego-based biotechnology company AltheaDx. Prior to AltheaDx, Noah was the vice president of global sales and market development at Verinata Health, where he led his team through the company’s acquisition by Illumina in 2013.
John Tan, SVP, Operations, Myriad Women's Health
John Tan is the senior vice president, operations of Myriad Women’s Health. Previously, John served as the senior vice president of operations, responsible for the clinical laboratory, scaling and optimizing operations including quality, supply chain, IT and engineering. With more than 25 years of experience in managing global manufacturing operations, he most recently served as vice president of global operations engineering at Amazon. In that role, John was responsible for the engineering design and capital procurement of a multi-billion dollar group for Amazon’s worldwide fulfillment centers, fresh/pantry facilities and transportation logistics. Prior to Amazon, he served in senior operations roles at both Thermo Fisher and PerkinElmer, both in the U.S. and abroad.
People Team Head, Counsyl
Peter Soparkar, JD, Chief Legal Officer &
People Team Head, Counsyl
Peter Soparkar joined Counsyl from Jazz Pharmaceuticals, where he led the legal team’s operations support and delivered on numerous debt and equity financings and four landmark transactions, including the launched tender-offer of Celator, the acquisitions of Italy-based Gentium, UK based EUSA Pharma, and the acquisition of and inversion into Ireland based Azur Pharma. Prior to Jazz, Peter worked at Latham & Watkins in London and San Francisco, with a practice spanning international and domestic markets, as well as private and public transactions. His deep life-sciences legal experience includes support for development activities, corporate governance, legal and regulatory compliance, public companies and compliant commercial activities. He received a J.D. from New York University and a B.A. from Oberlin College.
In the community
We continue to support activities that encourage people to access screening and make choices that are right for their families. To this end, Counsyl has worked with several non-profit organizations to raise awareness and make screening as simple as possible. Our community involvement extends beyond screening too. Our employees are passionate about giving back and we provide opportunities to do so.
Counsyl is a proud contributor to the Free the Data movement, which encourages scientific collaboration with the aim of providing better information for more people.
Our employees are passionate about giving back to the communities in which we live and work. Through the efforts of our Counsyl Cares initiative, employees are provided with opportunities to volunteer, fundraise or participate in various non-profit sponsored events.